Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD study

被引：0

作者：

Ribaldone, D. G. ^{[1
]}

Parisio, L. ^{[2
]}

Variola, A. ^{[3
]}

Bossa, F. ^{[4
]}

Castiglione, F. ^{[5
]}

Marzo, M. ^{[6
]}

Piazza, N. ^{[7
]}

Aratari, A. ^{[8
]}

Savarino, E. V. ^{[9
]}

Bodini, G. ^{[10
]}

Mastronardi, M. ^{[11
]}

Micheli, F. ^{[2
,12
]}

Mazzuoli, S. ^{[13
]}

Ascolani, M. ^{[14
]}

Vigano, C. ^{[15
,16
]}

Cappello, M. ^{[17
]}

Bezzio, C. ^{[18
]}

Ciccocioppo, R. ^{[19
,20
]}

Scardino, G. ^{[21
]}

Sarli, E. ^{[22
]}

Pugliese, D. ^{[2
]}

Scaldaferri, F. ^{[2
]}

Napolitano, D. ^{[2
]}

Todeschini, A. ^{[3
]}

Geccherle, A. ^{[3
]}

Colaci, N. ^{[23
]}

Guerra, M. ^{[4
]}

Annese, M. ^{[4
]}

Testa, A. ^{[5
]}

Caiazzo, A. ^{[5
]}

Conforti, F. S. ^{[7
]}

Festa, S. ^{[8
]}

Lorenzon, G. ^{[9
]}

Marra, A. ^{[11
]}

Magiotta, A. ^{[12
]}

Baccini, F. ^{[12
]}

Amato, A. ^{[24
]}

Vernero, M. ^{[1
]}

Caprioli, F. ^{[25
]}

Caviglia, G. P. ^{[1
]}

机构：

[1] Univ Turin, Dept Med Sci, Turin, Italy

[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, CEAMD IBD Unit, Rome, Italy

[3] IRCCS Osped Sacro Cuore Don Calabria, IBD Unit, Negrar Di Valpolicella, VR, Italy

[4] Fdn IRCCS Casa Sollievo della Sofferenza, Div Gastroenterol & Endoscopy, San Giovanni Rotondo, FG, Italy

[5] Sch Med Federico II Naples, Gastroenterol, Dept Clin Med & Surg, Naples, Italy

[6] Osped Veris delli Ponti, UOC Gastroenterol, Scorrano, LE, Italy

[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Gastroenterol & Endoscopy Unit, Milan, Italy

[8] San Filippo Neri Hosp, IBD Unit, Rome, Italy

[9] Univ Padua, Azienda Osped Univ Padova, Gastroenterol Unit, Dept Surgery Oncol & Gastroenterol, Padua, Italy

[10] Univ Genoa, Dept Internal Med, IRCCS Policlin San Martino, Genoa, Italy

[11] IRCCS S De Bellis, Unita Operat Semplice Dipartimentale IBD, Castellaneta Grotte, BA, Italy

[12] Sapienza Univ Rome, St Andrea Hosp, Digest Dis Unit, Rome, Italy

[13] Osped Dimiccoli Barletta, Gastroenterol & Endoscopy Unit, Barletta, Italy

[14] ULSS2 Marca Trevigiana Osped Ca Foncello, UOC Gastroenterol, Treviso, Italy

[15] Univ Milano Bicocca, Fdn IRCCS San Gerardo Tintori, Sch Med, Dept Gastroenterol, Monza, Italy

[16] European Reference Network Hepatol Dis ERN RARE L, Ctr Autoimmune Liver Dis, Monza, Italy

[17] AOUP P Giaccone, UOC Gastroenterol, Palermo, Italy

[18] ASST Rhodense, Rho Hosp, Gastroenterol Unit, IBD Ctr, Milan, Italy

[19] AOUI Policlin GB Rossi, Verona, Italy

[20] Univ Verona, Gastroenterol Unit, Dept Med, Verona, Italy

[21] Valduce Hosp, Dept Gastroenterol, Como, Italy

[22] Italian Grp Study Inflammatory Bowel Dis, IG IBD, Florence, Italy

[23] IRCCS Sacro Cuore Don Calabria, Unita Ric Clin, Negrar Di Valpolicella, VR, Italy

[24] ASST Lecco, Digest Endoscopy & Gastroenterol Dept, Lecce, Italy

[25] Univ Milan, Gastroenterol & Endoscopy Unit, Dept Pathophysiol & Transplantat, Fdn IRCCS Ca Granda,Osped Maggiore Policlin Milan, Milan, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P612

引用

页码：I1176 / I1176

页数：1

共 50 条

[31] Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy (RETUCAS): a Multicentre Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)
Macaluso, F. S.
Grova, M.
Bossa, F.
Carparelli, S.
Pugliese, D.
Cuccia, G.
Cappello, M.
Muscarella, S.
Saibeni, S.
Bezzio, C.
Armuzzi, A.
Gravina, G. A.
Pellegrino, R.
Caprioli, F. A.
Sorge, A.
Soriano, A.
Ribaldone, D. G.
Festa, S.
Variola, A.
Ferracane, C.
Onali, S.
Fantini, M. C.
Orlando, A.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2149 - i2149
[32] The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
Ye, Byong Duk
Cheon, Jae Hee
Song, Ki Hwan
Kim, Joo Sung
Kim, Young-Ho
Yoon, Hyuk
Lee, Kang-Moon
Kang, Sang-Bum
Jang, Byung Ik
Park, Jae Jun
Kim, Tae Oh
Lee, Dae-Wook
Foo, Chee Yoong
Shin, Jeong Eun
Park, Dong Il
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
[33] Inflammatory Bowel Disease Patients' Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience
Remy, Clotilde
Caron, Benedicte
Gouynou, Celia
Haghnejad, Vincent
Jeanbert, Elodie
Netter, Patrick
Danese, Silvio
Peyrin-Biroulet, Laurent
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
[34] Switching from intravenous to subcutaneous Infliximab in patients with immune mediated diseases in clinical remission
Viazis, N.
Karamanakos, A.
Mousourakis, K.
Christidou, A.
Fousekis, F.
Mpakogiannis, K.
Koukoudis, A.
Katsanos, K.
Christodoulou, D.
Cheila, M.
Tzouvala, M.
Zacharopoulou, E.
Palatianou, M.
Giouleme, O.
Katsoula, A.
Liatsos, C.
Kyriakos, N.
Zampeli, E.
Papathanasiou, E.
Theodoropoulou, A.
Karmiris, K.
Psaroudakis, I
Tribonias, G.
Gazi, S.
Mole, E.
Dimitroulas, T.
Koutsianas, C.
Vasilopoulos, D.
Fragoulis, G.
Michalakeas, N.
Papagoras, C.
Panagakis, P.
Papoutsaki, M.
Chasapi, V
Stratigos, A.
Katsikas, G.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1773 - i1773
[35] The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis:: An *IG-IBD study
Andruilli, A
Annese, V
Latiano, A
Palmieri, O
Fortina, P
Ardizzone, S
Cottone, M
D'Inca, R
Riegler, G
GASTROENTEROLOGY, 2004, 126 (02) : 625 - 627
[36] Diagnostic interobserver variability in Crohn’s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group
G. Leoncini
F. Donato
L. Reggiani-Bonetti
T. Salviato
M. Cadei
M. Daperno
M. B. Principi
A. Armuzzi
F. Caprioli
G. Canavese
V. Villanacci
Techniques in Coloproctology, 2021, 25 : 101 - 108
[37] Fecal calprotectin as a predictor of histological remission in patients with ulcerative colitis treated with vedolizumab: A retrospective cohort study
Rubtsov, D.
Ramaswamy, P. Kakkadasam
Mohsen, W.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 104 - 104
[38] Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group
Leoncini, G.
Donato, F.
Reggiani-Bonetti, L.
Salviato, T.
Cadei, M.
Daperno, M.
Principi, M. B.
Armuzzi, A.
Caprioli, F.
Canavese, G.
Villanacci, V.
TECHNIQUES IN COLOPROCTOLOGY, 2021, 25 (01) : 101 - 108
[39] Vedolizumab trough concentrations and histological remission in Ulcerative Colitis: Results from the LOVE-UC study
Hanzel, J.
Baert, F.
Lowenberg, M.
Ferrante, M.
Bossuyt, P.
Hoentjen, F.
Franchimont, D.
Palatka, K.
Peeters, H.
Mookhoek, A.
de Hertogh, G.
Clasquin, E.
Vermeire, S.
D'Haens, G.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 625 - 626
[40] An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
D'Amico, Ferdinando
Massimino, Luca
Palmieri, Giulia
Buono, Arianna Dal
Gabbiadini, Roberto
Caron, Benedicte
Moreira, Paula
Silva, Isabel
Bosca-Watts, Maia
Innocenti, Tommaso
Dragoni, Gabriele
Bezzio, Cristina
Zilli, Alessandra
Furfaro, Federica
Saibeni, Simone
Chaparro, Maria
Garcia, Maria Jose
Michalopoulos, George
Viazis, Nikos
Mantzaris, Gerassimos J.
Ellul, Pierre
Gisbert, Javier P.
Magro, Fernando
Peyrin-Biroulet, Laurent
Armuzzi, Alessandro
Ungaro, Federica
Danese, Silvio
Fiorino, Gionata
Allocca, Mariangela
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (11)

← 1 2 3 4 5 →